Prolonged post-transplant ruxolitinib therapy is associated with protection from severe gvhd after allogeneic HCT Meeting Abstract
| Authors: | DeFilipp, Z.; Kim, H. T.; Knight, L.; Kelley, D.; Byrne, M. T.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; Vasu, S.; Abedin, S.; El-Jawahri, A. R.; McAfee, S. L.; Chen, Y. B.; Hobbs, G. |
| Abstract Title: | Prolonged post-transplant ruxolitinib therapy is associated with protection from severe gvhd after allogeneic HCT |
| Meeting Title: | 2022 Tandem Meetings of ASTCT and CIBMTR |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 28 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Apr 23-26 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-03-01 |
| Start Page: | S305 |
| End Page: | S306 |
| Language: | English |
| DOI: | 10.1016/S2666-6367(22)00553-X |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: 393 -- Located within the section named "Poster Session - Graft-Versus-Host And Graft-Versus-Tumor - Clinical Prevention, Treatment And Biomarkers" |
